top of page

Prof. Dr. med. Steffen Stürzebecher

  • LinkedIn
  • Honorary professor for the field of basic medical science at Faculty 1 of the HTW Berlin, engineering sciences - energy and information

  • Specialist in Pharmacology

Over 35 years of experience and responsibility in all phases of the development of innovative drugs:

  • at the companies Schering AG (Head of Clinical Development HK & CNS), Grünenthal GmbH (Head of Clinical Development, Chief Medical Officer), Glenmark Pharmaceuticals (Head of Clinical R&D & CMO) and in Consulting (4 years)

  • for NCEs & NBEs in a wide range of indications (including CNS with a focus on neurodegeneration, pain, cardiovascular, pulmonary, autoimmune diseases) and with a focus on rare diseases,

  • in preclinical research, pharmacogenomics, biomarker development and translational medicine,

  • from phase I to phase III, in phase IIIb and IV & non-interventional studies,

  • in the preparation of (successful) approval dossiers (also as a clinical expert), benefit assessments (HTAs) and the preparation and implementation of market launches,

  • in due diligence processes and the critical "deep dive" evaluation of portfolios.

bottom of page